Hi!

I am a postdoctoral fellow at Dana-Farber Cancer Institute in the Department of Medical Oncology. I combine experimental and computational approaches to uncover the biological mechanisms driving therapeutic resistance and immune responses in rare and treatment-refractory kidney cancers. My work integrates immunology, cancer genetics, and translational genomics to develop personalized immunotherapies and combination treatments. I am also deeply committed to fostering collaboration and mentorship in scientific research.

I completed my PhD in Cancer Immunology from Dalhousie University, where my thesis focused on developing mass-spectrometry based approaches for tumor antigen discovery, and immunogenic photodynamic therapies to enhance T cell-mediated immune responses in mouse melanoma models. I hold a Bachelor’s degree in Biotechnology from the Indian Institute of Technology Madras.

Beyond research, I actively advocate for improved mentorship, gender equity, and graduate student mental health. I currently serve in leadership roles within postdoctoral associations and previously co-founded the Graduate Student Peer Support Network at Dalhousie. I’m always happy to connect on science, mentorship, or advocacy.

When I’m not in the lab, you’ll likely find me painting, stargazing, or unwinding with a good book, great food, and even better company. I also enjoy being outdoors - whether it’s running, biking, or simply exploring. You can check out my current reads on Goodreads and my artwork on DoodlePhD.

Education

Postdoctoral Fellow, Medicine

2022 - current
Harvard Medical School, USA

Postdoctoral Fellow, Medical Oncology

2022 - current
Dana-Farber Cancer Institute, USA

PhD, Microbiology & Immunology

2015 - 2022
Dalhousie University, Canada

B.Tech, Biotechnology

2011 - 2015
Indian Institute of Technology (IIT) Madras, India

Selected Awards and Fellowships

KCRP FY22, Postdoctoral and Clinical Fellowship Award

2023-2026
Department of Defense, Congressionally Directed Medical Research Programs, USA

Faculty of Medicine Excellence in Research Award

2021-2021
Dalhousie University, Canada

Dalhousie Medical Research Foundation-I3V Graduate Studentship

2021-2023
Dalhousie University, Canada

Isaac Walton Killam Memorial Predoctoral Scholarship

2019-2021
Isaac Killam Foundation, Canada

President’s Award

2019-2019
Dalhousie University, Canada

Scotia Scholars Doctoral Scholarship

2019-2021
Research Nova Scotia, Canada

Nova Scotia Predoctoral Scholarship

2017-2021
Government of Nova Scotia, Canada

Nova Scotia Graduate Scholarship for Masters

2016-2017
Government of Nova Scotia, Canada

Indian Academy of Sciences Summer Research Fellowship

2013-2013
Indian Academy of Science, India

Teaching Experience

Cell Biology (Theory & Laboratory), Department of Biology, Dalhousie University - 2018-2021
Basic Microbiology and Immunology for Pharmacy, Department of Microbiology & Immunology, Dalhousie University - 2018-2019
Introductory Microbiology and Immunology, Department of Microbiology & Immunology, Dalhousie University - 2018 Summer

Selected Publications

check Google Scholar for all publications

  • Genome-guided Discovery of Cancer Therapeutic Targets.
  • Konda P*, Garinet S*, VanAllen E, & Viswanathan SR.
    Cell Reports. 2023.
  • Androgen Receptor How splicing confers treatment resistance in prostate cancer.
  • Konda P & Viswanathan S.
    eLife Insight Article. 2022.
  • Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell death.
  • Konda P*, Roque III J A*, Lifshits L M*, Alcos A, Azzam E, Shi G, Cameron C G, McFarland S A & Gujar S.
    American Journal of Cancer Research. 2022.
  • Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy.
  • Konda P*, Lifshits L M*, Roque III J A*, Cole H D, Cameron C G, McFarland S A & Gujar S.
    OncoImmunology. 2021.
  • Near-infrared absorbing Ru (ii) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma.
  • Lifshits L M *, Roque III J A *, Konda P*, Monro S, Cole HD, von Dohlen D, Kim S, Deep G, Thummel RP, Cameron C G, Gujar S & McFarland S A.
    Chemical Science. 2020.
  • Improving MHC-I ligand identification by incorporating targeted searches of mass spectrometry data.
  • Konda P, Murphy J P, Gujar S.
    Methods in Molecular Biology Bioinformatics. 2020.
  • Enhancing Mass Spectrometry-Based MHC-I Peptide Identification Through a Targeted Database Search Approach.
  • Konda P, Murphy J P, Neilsen M, Gujar S.
    Methods in Molecular Biology Immunoproteomics, second edition. 2019.
  • MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data- Implications for T-Cell Immunotherapies.
  • Murphy J*, Konda P*, Kowalewski DJ, Schuster H, Clements D, Kim Y, Cohen A M, Sharif T, Nielsen M, Stevanovic S, Lee P W & Gujar S.
    Journal of Proteome Research. 2017. ACS editor’s choice article 2016-2017.